Recent Study: Oxford Biodynamics Limited - Product Pipeline Analysis, 2014 Update
Oxford Biodynamics Limited (Oxford Bio) is a biotechnology company. The company develops biomarker discovery platform. It discovers biomarker discovery platform EpiSwitch for the detection of aberrant gene expression. The company's products is used for detection, monitoring and prognosis of major diseases associated with aberrant gene expression including oncology, inflammatory, metabolic, cardiovascular and neurodegenerative conditions. Oxford Bio's products under clinical development include OBD 27, OBD 29, OBD 35, OBD 73, OBD 26, OBD 85, OBD 87 and OBD. Its products are...
View full press release